On January 24, 2025, the Trump administration's White House Presidential Personnel Office notified multiple scientists serving on the National Science Foundation's National Science Board of their termination, effective immediately. The removal occurred through direct messaging rather than formal administrative procedure, with the Personnel Office providing brief acknowledgment of the departing members' service. No specific statutory authority or executive order number was cited in the notification, suggesting the action proceeded under the president's general appointment and removal powers over federal advisory board members.

The National Science Board serves as the primary policy advisory body to the NSF, which distributes roughly $10 billion annually in research funding across American universities and laboratories. The terminated members included active researchers whose expertise spans multiple scientific disciplines. Their removal reduces the board's scientific advisory capacity precisely when federal science governance faces heightened scrutiny and restructuring. These board members had provided recommendations on NSF priorities, funding mechanisms, and alignment between research investments and national needs.

This termination represents an escalation in a systematic restructuring of federal scientific institutions. It follows the January 23 dissolution of the President's Council of Advisors on Science and Technology—the government's highest-level science advisory body—which eliminated direct presidential access to cross-agency scientific counsel. Simultaneously, the administration has moved to control scientific outputs, as evidenced by the CDC's suppression of peer-reviewed vaccine efficacy data in April 2026. These actions collectively diminish institutional mechanisms through which career scientists influence federal policy, replacing broad scientific input with executive-directed priorities.

The removal of advisory board members through personnel office messaging, rather than transparent administrative process, raised questions about procedural regularity, though the administration's legal authority to remove members from policy-advisory boards remained largely unchallenged in court. No immediate congressional response or litigation emerged in documented records, though the action fell within a broader pattern that drew criticism from scientific societies and research institutions.

Reversal would require the administration to reconstitute the board with dismissed members or equivalent scientific representation, restoring the advisory function and restoring institutional balance between executive direction and scientific input in NSF governance.